European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.
Tatsch
K
K
Asenbaum
S
S
Bartenstein
P
P
Catafau
A
A
Halldin
C
C
Pilowsky
L S
LS
Pupi
A
A
D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D001931:Brain Mapping / Q000379:methods; D050483:Dopamine Plasma Membrane Transport Proteins; D005060:Europe; D006801:Humans; D007391:International Cooperation; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D008024:Ligands; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000378:metabolism*; D009419:Nerve Tissue Proteins; D009683:Nuclear Medicine / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic / Q000592:standards; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012955:Societies, Medical; D009435:Synaptic Transmission / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods / Q000592:standards*
D050483:Dopamine Plasma Membrane Transport Proteins; D007457:Iodine Radioisotopes; D008024:Ligands; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D019275:Radiopharmaceuticals